Sobre la Empresa
- Nombre legal: Transo-Pharm Handels GmbH
- País de registro: Germany
- Dirección: Bueltbek 5, 22962 Siek
- Número de empleados: 25 - 49
Descripción:
Transo-Pharm, founded in 1987, is a fully licensed global distributor of pharmaceutical components for health and veterinary industries. It supports customers throughout the API lifecycle, from development to sales, offering diverse products and qualifying manufacturers for compliance. Acting as a sourcing and regulatory marketing agent, Transo-Pharm has offices in Shanghai, Hong Kong, Singapore, the United States, and an affiliated office in Mumbai. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Actividades Comerciales
Ingredientes Farmacéuticos Activos (API)
DistribuidorUnidad LogísticaConsultor Regulatorio
Clasificación ATC (Anatómica, Terapéutica, Química)
DistribuidorUnidad LogísticaConsultor Regulatorio
IFA de Marca Original
DistribuidorUnidad LogísticaConsultor Regulatorio
Servicios Regulatorios e Inteligencia de Mercado
Proveedor de Servicios
Productos/Servicios Clave
- Ingredientes Farmacéuticos Activos (API): Hyoscine N-Butylbromide (CEP), Ajmaline (ASMF), Noscapine (ASMF), Scopolamine Hydrobromide (CEP / US-DMF), Scopolamine Methylbromide (US-DMF), Doxorubicin HCl (CEP), Epirubicin HCl ( CEP / US-DMF), Idarubicin HCl (ASMF / US-DMF), Nelarabine (US-DMF), Valrubicin (US-DMF), Epinephrine Base (CEP / US-DMF), Epinephrine Bitartrate (CEP / US-DMF), Estriol (CEP), Norepinephrine bitartrate (CEP / US-DMF), Thyroid Extract (USP), Dorzolamide HCl (CEP), Acetylcysteine (CEP), Crotamiton (CEP / US-DMF), Dexmedetomidine (ASMF), Guaifenesin (CEP / US-DMF), Hyoscine (CEP), Levosimendan (ASMF), Methocarbamol (ASMF / US-DMF), Nonivamide (ASMF), Phenylephrine HCl (CEP / US-DMF), Tranexamic Acid (CEP)
- IFA de Marca Original: Digoxin (CEP / US-DMF)
- Productos Farmacéuticos Veterinarios y Aditivos para Piensos: Clenbuterol HCl (CEP / US-VMF)
Nuestros Productos & Servicios
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
Certificado CEP
DMF
GMP
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario